Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
Tenschert
W
W
Department of Urology, University of Hamburg-Eppendorf, Germany.
Gonnermann
D
D
Meyer-Moldenhauer
W H
WH
Cremaschi
L
L
Huland
H
H
D000328:Adult; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir